Vytrus Biotech, S.A. (BME:VYT)

Revenue by Segment

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Personal Products	9.69M	6.09M	4.70M	4.48M	3.51M
Personal Products Growth	59.15%	29.51%	4.90%	27.57%	57.47%
Total	9.69M	6.09M	4.70M	4.48M	3.51M
Total Growth	59.15%	29.51%	4.90%	27.57%	57.47%

Revenue by Geography

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Spain	2.59M	1.51M	1.47M	1.26M	1.03M
Spain Growth	71.21%	2.88%	17.01%	21.32%	31.43%
European Union	2.62M	1.67M	1.09M	1.38M	1.20M
European Union Growth	56.86%	53.19%	-20.88%	14.57%	93.35%
Other Export	3.17M	1.87M	1.18M	1.05M	568.32K
Other Export Growth	69.82%	58.23%	12.22%	84.86%	91.81%
Total	8.37M	5.04M	3.74M	3.68M	2.80M
Total Growth	65.95%	35.00%	1.48%	31.31%	64.49%

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2024

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Jun 26, 2026

Data Sources Report a data error